Prognostic factors associated with survival in patients with wild-type transthyretin amyloid cardiomyopathy, treated with tafamidis

Back

HFA Premium Access

Prognostic factors associated with survival in patients with wild-type transthyretin amyloid cardiomyopathy, treated with tafamidis

Session: ePosters in chronic heart failure - epidemiology, prognosis, outcome 3

Topic: Epidemiology, Prognosis, Outcome

Speaker: Assistant Professor G. Zemljic (Ljubljana, SI)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Assistant Professor Gregor Zemljic

University Medical Centre Ljubljana, Ljubljana (Slovenia)

0 follower

7 more presentations in this session

Prevalence, outcomes and the correlates of stress induced hyperglycemia among patients admitted for acute heart failure

Speaker: Doctor D. Mabula (Mwanza, TZ)

Lenght of stay in patients with acutely decompensated heart failure with reduced ejection fraction - associated factors and predictors

Speaker: Doctor J. Stevic (Belgrade, RS)

Impact of BNP levels as predictors of prognosis in heart failure patients with ARNI

Speaker: Doctor D. maebuchi (kuki, JP)

Impact of optimized therapy on the evolution of patients with heart failure - reality of an advanced heart failure outpatient clinic of the unified health system

Speaker: Doctor G. Assink De Castro (Curitiba, BR)

Are patients with de novo and chronic heart failure with reduced ejection fraction different? Results of a contemporary registry.

Speaker: Doctor J. Bonilla Palomas (Ubeda, ES)

Access the full session

ePosters in chronic heart failure - epidemiology, prognosis, outcome 3

Speakers: Assistant Professor G. Zemljic, Doctor D. Mabula, Doctor J. Stevic, Doctor D. maebuchi, Doctor G. Assink De Castro...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources